Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Rockwell Medical Inc. | 1 | 0 | 0 | 0 | €1.60 | €3.00 | 87.735% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €97.30 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €42.00 | - | - |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €6.85 | €8.75 | 27.737% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.84 | - | - |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.55 | €11.00 | 67.888% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.19 | €26.01 | 28.808% |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.70 | €30.00 | 104.082% |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.72 | €5.00 | 5.932% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.64 | - | - |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | €14.89 | €28.06 | 88.428% |
| Phibro Animal Health Corp. A | 3 | 2 | 0 | 1 | €15.50 | €12.06 | -22.168% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €54.30 | €78.42 | 44.424% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €2.15 | €8.35 | 288.864% |
| Pfizer Inc. | 27 | 5 | 0 | 1 | €27.18 | €40.66 | 49.593% |
| Lexicon Pharmaceuticals Inc. | 2 | 0 | 0 | 0 | €1.78 | €5.34 | 199.775% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.31 | €3.70 | 182.227% |
| Geron Corp. | 12 | 0 | 0 | 0 | €3.67 | €4.63 | 25.906% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.46 | - | - |
| Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €217.00 | €315.00 | 45.161% |
| Repligen Corp. | 13 | 0 | 0 | 0 | €138.65 | €184.76 | 33.256% |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €43.40 | €50.00 | 15.207% |